Table 1. Baseline clinical and angiographic characteristics.
| Baseline characteristics † | MT alone (n=124) | PCI (n=251) | CABG (n=79) | P value |
|---|---|---|---|---|
| Age (years) | 61.9±10.2 | 60.8±9.4 | 61.7±8.4 | 0.496 |
| Male | 69 (55.6)¶ | 173 (68.9) | 54 (68.4) | 0.032 |
| Race white | 87 (70.2) | 176 (70.1) | 61 (77.2) | 0.449 |
| School degree (years) | 5 [3–8] | 5 [4–9] | 6 [4–10] | 0.227 |
| BMI (kg/m²) | 28.9±5.2b | 28.1±4.3ab | 27.4±4.2a | 0.050 |
| SBP (mmHg) | 141.9±23.5 | 141.1±23.9 | 144.8±20.6 | 0.473 |
| DBP (mmHg) | 79.7±11.9 | 81.5±12.9 | 83.2±11.6 | 0.130 |
| Hypertension | 114 (91.9) | 236 (94.0) | 76 (96.2) | 0.460 |
| Diabetes mellitus | 42 (33.9) | 71 (28.3) | 31 (39.2) | 0.158 |
| Previous myocardial infarction | 45 (36.3) ¶ | 127 (50.6) | 51 (64.6)§ | <0.001 |
| HF | 19 (15.3) | 40 (15.9) | 17 (21.5) | 0.452 |
| LVFE (%) | 62.6±14.1 | 63.2±14.9 | 58.3±15.9 | 0.054 |
| Glucose (mg/dL) | 103.4±33.1 | 106.5±27.8 | 114.7±45.9 | 0.054 |
| Total Cholesterol (mg/dL) | 170.4±47.3 | 170.6±45.3 | 176.6±51.8 | 0.575 |
| HDL-C (mg/dL) | 41.4±11.1 | 39.7±9.9 | 40.7±10.1 | 0.284 |
| Triglycerides (mg/dL) | 119.5 (87.0–173.8) | 125 (90.0–169.0) | 122 (91.0–176.0) | 0.896 |
| Creatinine (mg/dL) | 0.69±0.21 | 0.71±0.21 | 0.72±0.22 | 0.805 |
| hs-CRP (mg/dL) | 2.5 (0.8–5.8) | 2.8 (0.9–7.0) | 2.1 (0.8–5.0) | 0.242 |
| Smoking | 85 (68.5) | 168 (66.9) | 44 (55.7) | 0.129 |
| Current smoking | 16 (12.9) | 40 (15.9) § | 3 (3.8) ¶ | 0.020 |
| Chest pain | 29 (23.4) | 44 (17.5) | 15.0 (19.0) | 0.400 |
| Dyspnea | 44 (35.5) | 68 (27.1) | 26 (32.9) | 0.218 |
| 10-year ASCVD risk | 16.7 (8.2–24.2) | 15.6 (9.1–23.4) | 19.6 (11.2–28.1) | 0.061 |
| SXscore‡ | 4.3 (0–11)a | 8 (5–13)b | 21.5 (13–26.5)c | <0.001 |
| Low SXscore | 117 (94.4) § | 235 (93.6) § | 49 (62.0) ¶ | <0.001 |
| Intermediate SXscore | 5 (4.0) ¶ | 15 (6.0) ¶ | 21 (28.6) § | |
| High SXscore | 2 (1.6) | 1 (0.4) ¶ | 9 (11.4) § | |
| LMMCAD | 20 (16.1) ¶ | 75 (29.9) ¶ | 62 (78.5) § | <0.001 |
| Indication of coronary angiography | ||||
| Suggestive symptoms of CAD | 100 (80.6) | 209 (83.3) | 72 (91.1) | 0.128 |
| With a positive noninvasive test | 50 (40.3) | 86 (34.3) | 38 (48.1) | 0.076 |
| Other complaints | 11 (8.9) | 16 (6.4) | 8 (10.1) | 0.469 |
†, Variables were described by mean ± SD, median (P25–P75) or as number (percentage). ‡, Low SXscore <23; Intermediate SXscore =23–32; High SXscore >32. §, Statistically significant positive association by adjusted residuals test to 5% of significance. ¶, Statistically significant negative association by adjusted residuals test to 5% of significance. a.b.c, Equal letters do not differ by the Scheffé’s or Dunn’s Test at 5% significance. MT, medical-therapy; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HF, heart failure; LVFE, left ventricular fraction ejection; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; ASCVD, atherosclerotic cardiovascular disease; LMMCAD, left main or multivessel CAD; CAD, coronary artery disease; SXscore, SYNTAX score.